DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6
肿瘤异质性的DCE-MRI生物标志物可预测贝伐单抗和FOLFOX-6治疗后CRC肝转移灶的缩小。
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/bjc.2011.191
O'Connor, J P B; Rose, C J; Jackson, A; Watson, Y; Cheung, S; Maders, F; Whitcher, B J; Roberts, C; Buonaccorsi, G A; Thompson, G; Clamp, A R; Jayson, G C; Parker, G J M
